References
- Rubin DB. Multiple imputation after 181 years. JASA 1996; 91: 473–489.
- Miller RG, Petajan JH, Bryan WW et al. A placebo-controlled trial of recombinant human ciliary neurotrophic (rhCNTF) factor in amyotrophic lateral sclerosis. Ann Neurol 1996; 39: 256–260.
- ALS CNTF Treatment Study Group. A double-blind placebo- controlled clinical trial of subcutaneous recombinant human ciliary neurotrophic factor (rHCNTF) in amyo- trophic lateral sclerosis. Neurology 1996; 46: 1244–1249.
- Peto R, Pike MC, Armitage P et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. Br J Cancer 1976; 34: 585–612.
- Lacomblez L, Bensimon G, Leigh PN, Guillet P, Meininger V and the ALS/Riluzole Study Group. II. Dose ranging study of riluzole in amyotrophic lateral sclerosis. Lancet 1996; 347: 1425–1431.